A phase 3 prostate cancer trial of Candel’s oncolytic virus has met its primary endpoint, sending the stock up more than 200% ...
Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found ...
Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...
Montell Jordan is advocating for prostate cancer awareness and emphasizing the importance of early detection, particularly ...
A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in African men. The ...
Investigators assessed the oncologic benefit of salvage radiation therapy versus observation for men with biochemical recurrence after radical prostatectomy.
Treatment with five-fraction SBRT could be effective versus traditional radiation in certain patients with low- or ...
Adrian Wojnarowski is popular among the masses for his role as the NBA insider for Yahoo and ESPN. However, he decided to ...
Activating the GP130 protein slows prostate cancer growth and enhances immune response, offering a potential treatment for ...
Candel Therapeutics' experimental immunotherapy for prostate cancer significantly improved the time patients lived before their disease returned, helping the company's shares more than double in value ...